Navigation Links
Frost & Sullivan: Multi-Modality Breast Imaging Systems Spur Innovations in Europe
Date:8/26/2014

LONDON, Aug. 26, 2014 /PRNewswire/ -- National population-based screening programs for asymptomatic women aged 40 and above have been established in many European countries for early detection of breast cancer. With every passing year, this population cohort is expanding, spurring breast cancer screening rates and fuelling the need for breast imaging systems. With the number of women being diagnosed with breast cancer also bound to increase, the adoption of equipment for procedures such as biopsy and image guidance too will grow.

Logo - http://photos.prnewswire.com/prnh/20140826/139581

New analysis from Frost & Sullivan, Analysis of the European Breast Imaging Systems Market, finds that the market earned revenues of $988.3 million in 2013 and estimates this to reach $1,384.2 million in 2020. The study covers x-ray mammography, breast ultrasound, breast magnetic resonance imaging (MRI), molecular breast imaging (MBI), and breast computer-aided detection (CAD).

While mammography has been considered the 'gold standard' for breast screening, adjunct technologies such as breast ultrasound, breast MRI and MBI too are gaining traction as they improve the standards of diagnosis and treatment of breast cancers.

"The European market will continue to evolve as breast imaging systems vendors look for innovative technologies to battle the increasing rate of false positives and overcome limitations while scanning women with dense breast tissue," said Frost & Sullivan Healthcare Research Analyst Raghuraman Madanagopal. "3-D tomosynthesis, automated breast ultrasound and MBI are the results of such technological innovations that ensure maximum efficiency and minimum error rates."

However, sporadic reimbursement trends across countries may lead to equally sporadic uptake of these advanced modalities for breast imaging. While the more commonly performed mammography and the less expensive ultrasound procedures are reimbursed sufficiently, the trend changes for costly procedures such as MRI and MBI.

To overcome this restraint, many breast imaging facilities in Europe are employing multi-modality screening. This, in turn, is expected to drive the use of supplementary modalities such as breast ultrasound.

"Research studies in recent years have validated the benefits that multi-modality screening provides over regular mammography screening, since one modality can overcome the limitations of another," noted Madanagopal. "In accordance with this validation that a multi-modality approach improves the efficiency, specificity and sensitivity of breast cancer screening procedures, a wide product portfolio will be a core competitive factor in the European breast imaging systems market."

If you are interested in more information on this study, please email Anna Zanchi, Corporate Communications, at anna.zanchi@frost.com

Analysis of the European Breast Imaging Systems Market is part of the Advanced Medical Technologies Growth Partnership Service program. Frost & Sullivan's related studies include: US Nuclear Medicine and PET Imaging Systems Market, and European Ultrasound Market. All studies included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact
Anna Zanchi
Corporate Communications – Europe
P: +39.02.4851 6133
E: anna.zanchi@frost.com

http://www.frost.com 


'/>"/>
SOURCE Frost & Sullivan
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan: Healthcare Investor Focus on Malaysia Grows, Bolstered by Government Support and Medical Tourism
2. Frost & Sullivan Recognizes Baxano Surgical as a Leader in MIS Spine Innovation
3. Frost & Sullivan Honors Vitro Biopharma for its Outstanding Technological Innovations and Business Strategy in the Stem Cell Tools Industry
4. Frost & Sullivan Applauds F Cubed for its Game-Changing MRSA Screener, the NESDEP IU
5. Frost & Sullivan Honors Mobius Imaging for Developing a Mobile 32-Slice CT Scanner, the Airo Mobile Intraoperative CT
6. Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market
7. Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform
8. Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging
9. Frost & Sullivan Finds Wellness and Early Intervention Technologies Core Components in Healthcare Delivery Transformation
10. Frost & Sullivan Acknowledges Nanomades Unique Technology that Combines Multipoint Touch and Force Sensing on a Fully Flexible Substrate
11. Microlife Wins Accolades from Frost & Sullivan for its Unique Automated Oscillometric Blood Pressure Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... , March 1, 2017  Global biotherapeutics leader ... completed the largest ever Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) ... nd T reatment with H izentra ® ... demonstrate the efficacy, safety and tolerability of two different ... (Immune Globulin Subcutaneous [Human]), compared with placebo, in ...
(Date:3/1/2017)... PRINCETON, N.J. , March 1, 2017 ... SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" ... announced that several new analyses from Phase-1 and ... 2) of tildrakizumab, an investigational IL-23p19 inhibitor being ... will be presented at the 2017 Annual American ...
(Date:3/1/2017)... 1, 2017 El mismo sistema se mostrará en el Congreso ... ... The open MRI scanner - MROpen engineered and developed ... ... Reino Unido y la primera en Gales. El escáner se localizará en el nuevo centro ...
Breaking Medicine Technology:
(Date:3/1/2017)... York, NY (PRWEB) , ... March 01, 2017 , ... ... chiropractic and physical therapy, is pleased to announce the addition of Orthopaedic Surgeon ... and graduated cum laude from Cornell University with a Bachelor of Science degree ...
(Date:3/1/2017)... ... ... is Comfort for the Soul”: a loving account of a very special dog, the ... soul-healing comfort provided by God’s presence in the face of deep sorrow. “There is ... dog-loving medical professional whose work takes her to remote areas in the American Northwest, ...
(Date:3/1/2017)... , ... March 01, 2017 , ... “Marriage...God's Way: Key ... “Marriage...God's Way: Key To One Flesh” is the creation of published author Cecilia Chiam, ... Christian Faith Publishing, Cecilia Chiam‘s new book presents solutions to many marital problems with ...
(Date:3/1/2017)... ... March 01, 2017 , ... Adherence ... unveiled its Cannabis Compliance Program for Regulatory Agencies. The regulatory agency program is ... regulators with internal or outsourced compliance program options, as well as an app ...
(Date:2/28/2017)... , ... March 01, 2017 , ... Among America’s most ... League for Nursing, Beverly Malone, PhD, RN, FAAN, has been tapped through competitive ... prestigious biennial list compiled by the Modern Healthcare. She will join her colleagues at ...
Breaking Medicine News(10 mins):